oral contraceptive pill

PreclinicalSmall molecule

WWayne State University

oral contraceptive pill is one of 15 small molecule programs targeting Women. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

WomenCompleted

WomenPreclinical

Completed

Competition

Competitive Landscape

16 competitors in Women

#DrugCompanyPhaseTrials

Cytotec

Pfizer

Approved

3 2

Bexsero

GSK

Phase 3

1 3

Lynparza

AstraZeneca

Phase 1

1 4

Casodex

IIstituto Clinico Humanitas

Phase 1

1 5

Navitoclax

AbbVie

Phase 1

1 6

Aralen

Sanofi

Preclinical

1 7

Tractocile

GSK

Preclinical

1 8

Isentress

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

4 9

Salbutamol

GSK

Preclinical

1 10

Aygestin

Teva

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Polycystic Ovary Syndrome1 trial

Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy

Completed·UUniversity of Rochester·Phase 3·NCT00283816·36 enrolled

Women1 trial

71A/G HSD17B5 SNP and Effects of Oral Contraceptive Pill in PCOS Women

Completed·FFederal University of Rio Grande do Sul·N/A·NCT01372293·49 enrolled

Unspecified1 trial

Norethindrone for the Delay of Menstruation

Completed·WWayne State University·Phase 4·NCT03594604·17 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for oral contraceptive pill. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — oral contraceptive pill compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for oral contraceptive pill. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Wayne State University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: WWayne State University

oral contraceptive pill

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Polycystic Ovary Syndrome1 trial

Women1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News